Simon Nicholls, aged 55, is another person with Alzheimer’s who is featured in the CNN documentary and who took part in the ...

Doctors and patient advocates supporting pretreatment testing at times challenged FDA and other experts who aren't swayed by available evidence.

Late-onset Alzheimer's disease is a debilitating, progressive neurodegenerative disease that affects about 7 million ...

Eran Ovadya, NurExone’s CFO, expressed: “we sincerely appreciate the trust our investors have placed in us. The warrant exercises and private placement have generated slightly more than C$1.2 million, ...

The FDA didn't approve the therapy in EBV-positive post-transplant lymphoproliferative disease due to findings at a third-party manufacturing facility.

A new study clams dementia cases will double by 2060. Here’s what experts believe could be driving the rise in dementia rates ...

Shares of Atara Biotherapeutics ATRA plunged 40.5% on Thursday after the FDA issued a complete response letter (CRL) against ...

Huntington’s is an incurable and fatal genetic condition that progressively affects movement, balance and cognition. It is ...

Older people who regularly drink green tea have fewer brain lesions are characteristic of dementia than those who do not ...

A cutting-edge AI tool can now predict how well seed potatoes will grow into healthy potato plants. Developed by biologists ...

4G bands 1, 2, 3, 4, 5, 7, 8, 12, 13, 14, 17, 18, 19, 20, 25, 26, 29, 30, 38, 39, 40, 41, 66, 71 ...

Cases of dementia in the United States are expected to rise to 1 million per year by 2060, with Black individuals, women and ...